Aromatase mRNA Levels in Benign Prostatic Hyperplasia and Prostate Cancer

Background: Estrogens are suspected to play a role in the pathogenesis of benign prostatic hyperplasia (BPH) and prostate cancer. In this study, the expression of aromatase messenger ribonucleic acid (mRNA) was determined, and these levels were quantitated, in human prostatic tissues to evaluate the role of estrogens in the pathogenesis of BPH and prostate cancer.

[1]  N. Harada,et al.  Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. , 1992, Endocrinology.

[2]  S. Inkster,et al.  Aromatase and other inhibitors in breast and prostatic cancer , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  J. Karr,et al.  The possibility of aromatization of androgen in human prostate. , 1987, Journal of steroid biochemistry.

[4]  D. Killinger,et al.  The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. , 1983, Journal of steroid biochemistry.

[5]  J. Weisz.  In vitro assays of aromatase and their role in studies of estrogen formation in target tissues. , 1982, Cancer research.

[6]  F. Habib,et al.  Failure of human benign prostatic hyperplasia to aromatise testosterone. , 1982, Journal of steroid biochemistry.

[7]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[8]  H. Schweikert.  Conversion of Androstenedione to Estrone in Human Fibroblasts Cultured from Prostate, Genital and Nongenital Skin* , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  Schweikert Hu.  Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin. , 1979 .

[10]  D. Killinger,et al.  The interconversion and aromatization of androgens by human adipose tissue. , 1979, Journal of steroid biochemistry.

[11]  P. Walsh,et al.  The induction of prostatic hypertrophy in the dog with androstanediol. , 1976, The Journal of clinical investigation.

[12]  R. Bosch,et al.  Pathogenesis of benign prostatic hyperplasia. , 1991, European urology.

[13]  B. Neubauer.  Endocrine and Cellular Inductive Factors in the Development of Human Benign Prostatic Hypertrophy , 1983 .

[14]  Chung Lee,et al.  Effects of Castration, Estrogen, and Androgen Administration , 1983 .

[15]  G. Murphy,et al.  Cellular Growth and Hormone Receptors , 1983 .

[16]  R. Ghanadian.  Hormonal control and rationale for endocrine therapy of prostatic tumours , 1983 .

[17]  R. Ghanadian.  The Endocrinology of Prostate Tumours , 1983, Springer Netherlands.